TP53 and neoplasm: In a series of outstanding experiments using mice with carefully designed mutations that include those giving temporal control of p53 expression in established autochthonous tumours, researchers have used immunocompetent mouse models bearing complex mutations to show that spontaneous tumours arising in the context of p53 deficiency were extremely sensitive to reactivation of p53 [58–60].